nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Mitoxantrone—multiple sclerosis	0.71	1	CiPCiCtD
Teniposide—TOP2A—Mitoxantrone—multiple sclerosis	0.0594	0.301	CbGbCtD
Teniposide—ABCG2—Cladribine—multiple sclerosis	0.0302	0.153	CbGbCtD
Teniposide—ABCG2—Mitoxantrone—multiple sclerosis	0.022	0.112	CbGbCtD
Teniposide—ABCG2—Dexamethasone—multiple sclerosis	0.0114	0.0579	CbGbCtD
Teniposide—CYP3A4—Fingolimod—multiple sclerosis	0.0101	0.0513	CbGbCtD
Teniposide—ABCG2—Methotrexate—multiple sclerosis	0.00919	0.0465	CbGbCtD
Teniposide—CYP2C19—Prednisone—multiple sclerosis	0.00818	0.0414	CbGbCtD
Teniposide—CYP3A4—Methylprednisolone—multiple sclerosis	0.00653	0.0331	CbGbCtD
Teniposide—CYP3A5—Dexamethasone—multiple sclerosis	0.00633	0.0321	CbGbCtD
Teniposide—CYP2C19—Dexamethasone—multiple sclerosis	0.00511	0.0259	CbGbCtD
Teniposide—CYP3A4—Triamcinolone—multiple sclerosis	0.00495	0.0251	CbGbCtD
Teniposide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00476	0.0241	CbGbCtD
Teniposide—CYP2C9—Dexamethasone—multiple sclerosis	0.00425	0.0215	CbGbCtD
Teniposide—CYP3A4—Betamethasone—multiple sclerosis	0.00425	0.0215	CbGbCtD
Teniposide—CYP3A4—Prednisolone—multiple sclerosis	0.00419	0.0212	CbGbCtD
Teniposide—CYP3A4—Prednisone—multiple sclerosis	0.00396	0.02	CbGbCtD
Teniposide—CYP3A4—Dexamethasone—multiple sclerosis	0.00247	0.0125	CbGbCtD
Teniposide—NCOA1—retina—multiple sclerosis	0.00117	0.105	CbGeAlD
Teniposide—NCOA1—medulla oblongata—multiple sclerosis	0.000849	0.0758	CbGeAlD
Teniposide—NCOA3—brainstem—multiple sclerosis	0.000848	0.0757	CbGeAlD
Teniposide—NCOA3—retina—multiple sclerosis	0.000818	0.073	CbGeAlD
Teniposide—NCOA1—midbrain—multiple sclerosis	0.000776	0.0693	CbGeAlD
Teniposide—NCOA1—spinal cord—multiple sclerosis	0.000757	0.0676	CbGeAlD
Teniposide—ABCC6—retina—multiple sclerosis	0.000719	0.0642	CbGeAlD
Teniposide—NCOA1—cerebellum—multiple sclerosis	0.0006	0.0536	CbGeAlD
Teniposide—NCOA3—medulla oblongata—multiple sclerosis	0.000591	0.0528	CbGeAlD
Teniposide—NCOA3—midbrain—multiple sclerosis	0.000541	0.0482	CbGeAlD
Teniposide—NCOA3—spinal cord—multiple sclerosis	0.000527	0.0471	CbGeAlD
Teniposide—NCOA1—brain—multiple sclerosis	0.000487	0.0435	CbGeAlD
Teniposide—NCOA3—nervous system—multiple sclerosis	0.000444	0.0397	CbGeAlD
Teniposide—NCOA3—central nervous system—multiple sclerosis	0.000428	0.0382	CbGeAlD
Teniposide—NCOA3—cerebellum—multiple sclerosis	0.000418	0.0373	CbGeAlD
Teniposide—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.000378	0.378	CbGdCrCtD
Teniposide—NCOA3—brain—multiple sclerosis	0.00034	0.0303	CbGeAlD
Teniposide—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.000264	0.265	CbGdCrCtD
Teniposide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000177	0.00619	CbGpPWpGaD
Teniposide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000177	0.00619	CbGpPWpGaD
Teniposide—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000174	0.00611	CbGpPWpGaD
Teniposide—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000174	0.00611	CbGpPWpGaD
Teniposide—ABCG2—medulla oblongata—multiple sclerosis	0.000173	0.0154	CbGeAlD
Teniposide—NCOA1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000172	0.00602	CbGpPWpGaD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—MAPK1—multiple sclerosis	0.000169	0.00593	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.000168	0.00588	CbGpPWpGaD
Teniposide—Tachycardia—Cladribine—multiple sclerosis	0.000163	0.00313	CcSEcCtD
Teniposide—Hyperhidrosis—Cladribine—multiple sclerosis	0.000162	0.0031	CcSEcCtD
Teniposide—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000161	0.161	CbGdCrCtD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	0.000161	0.00564	CbGpPWpGaD
Teniposide—Anorexia—Cladribine—multiple sclerosis	0.00016	0.00306	CcSEcCtD
Teniposide—Sepsis—Prednisone—multiple sclerosis	0.00016	0.00306	CcSEcCtD
Teniposide—ABCG2—midbrain—multiple sclerosis	0.000158	0.0141	CbGeAlD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000158	0.00552	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000157	0.0055	CbGpPWpGaD
Teniposide—Hypotension—Cladribine—multiple sclerosis	0.000157	0.003	CcSEcCtD
Teniposide—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000156	0.00298	CcSEcCtD
Teniposide—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000155	0.00297	CcSEcCtD
Teniposide—Anaemia—Azathioprine—multiple sclerosis	0.000154	0.00295	CcSEcCtD
Teniposide—ABCG2—spinal cord—multiple sclerosis	0.000154	0.0138	CbGeAlD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000153	0.00535	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000153	0.00535	CbGpPWpGaD
Teniposide—Leukopenia—Azathioprine—multiple sclerosis	0.000149	0.00286	CcSEcCtD
Teniposide—Dyspnoea—Cladribine—multiple sclerosis	0.000149	0.00286	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	0.000146	0.00513	CbGpPWpGaD
Teniposide—Decreased appetite—Cladribine—multiple sclerosis	0.000146	0.00279	CcSEcCtD
Teniposide—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000143	0.00275	CcSEcCtD
Teniposide—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000143	0.00502	CbGpPWpGaD
Teniposide—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000143	0.00502	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—STAT3—multiple sclerosis	0.00014	0.00489	CbGpPWpGaD
Teniposide—NCOA1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000139	0.00488	CbGpPWpGaD
Teniposide—Chills—Mitoxantrone—multiple sclerosis	0.000139	0.00266	CcSEcCtD
Teniposide—Neoplasm—Methotrexate—multiple sclerosis	0.000139	0.00266	CcSEcCtD
Teniposide—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000139	0.00266	CcSEcCtD
Teniposide—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000138	0.00265	CcSEcCtD
Teniposide—Feeling abnormal—Cladribine—multiple sclerosis	0.000138	0.00264	CcSEcCtD
Teniposide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000137	0.00262	CcSEcCtD
Teniposide—Alopecia—Mitoxantrone—multiple sclerosis	0.000137	0.00262	CcSEcCtD
Teniposide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000137	0.00478	CbGpPWpGaD
Teniposide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000137	0.00478	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000135	0.00474	CbGpPWpGaD
Teniposide—Infection—Azathioprine—multiple sclerosis	0.000135	0.00259	CcSEcCtD
Teniposide—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000135	0.00472	CbGpPWpGaD
Teniposide—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000135	0.00472	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	0.000134	0.00469	CbGpPWpGaD
Teniposide—Sepsis—Methotrexate—multiple sclerosis	0.000133	0.00256	CcSEcCtD
Teniposide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000133	0.00255	CcSEcCtD
Teniposide—Urticaria—Cladribine—multiple sclerosis	0.000133	0.00255	CcSEcCtD
Teniposide—Abdominal pain—Cladribine—multiple sclerosis	0.000132	0.00254	CcSEcCtD
Teniposide—Body temperature increased—Cladribine—multiple sclerosis	0.000132	0.00254	CcSEcCtD
Teniposide—NCOA1—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	0.00013	0.00455	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000129	0.00453	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000129	0.00453	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000129	0.00453	CbGpPWpGaD
Teniposide—Haemoglobin—Prednisolone—multiple sclerosis	0.000128	0.00245	CcSEcCtD
Teniposide—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000128	0.00244	CcSEcCtD
Teniposide—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000127	0.00244	CcSEcCtD
Teniposide—Hypotension—Azathioprine—multiple sclerosis	0.000127	0.00244	CcSEcCtD
Teniposide—Haemorrhage—Prednisolone—multiple sclerosis	0.000127	0.00243	CcSEcCtD
Teniposide—NCOA1—IL-6 signaling pathway—MAPK1—multiple sclerosis	0.000127	0.00444	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000126	0.00442	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000126	0.00442	CbGpPWpGaD
Teniposide—Anaemia—Mitoxantrone—multiple sclerosis	0.000125	0.00239	CcSEcCtD
Teniposide—Sweating—Methylprednisolone—multiple sclerosis	0.000125	0.00239	CcSEcCtD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000125	0.00436	CbGpPWpGaD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000125	0.00436	CbGpPWpGaD
Teniposide—Hypersensitivity—Cladribine—multiple sclerosis	0.000123	0.00236	CcSEcCtD
Teniposide—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000123	0.00431	CbGpPWpGaD
Teniposide—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000123	0.00431	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000123	0.00429	CbGpPWpGaD
Teniposide—ABCG2—cerebellum—multiple sclerosis	0.000122	0.0109	CbGeAlD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000122	0.00426	CbGpPWpGaD
Teniposide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000121	0.00231	CcSEcCtD
Teniposide—Asthenia—Cladribine—multiple sclerosis	0.00012	0.0023	CcSEcCtD
Teniposide—Pruritus—Cladribine—multiple sclerosis	0.000119	0.00227	CcSEcCtD
Teniposide—Haemoglobin—Triamcinolone—multiple sclerosis	0.000118	0.00225	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—FAS—multiple sclerosis	0.000117	0.00411	CbGpPWpGaD
Teniposide—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000117	0.00225	CcSEcCtD
Teniposide—Haemorrhage—Triamcinolone—multiple sclerosis	0.000117	0.00224	CcSEcCtD
Teniposide—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000117	0.00223	CcSEcCtD
Teniposide—Hypertension—Mitoxantrone—multiple sclerosis	0.000116	0.00223	CcSEcCtD
Teniposide—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000116	0.00222	CcSEcCtD
Teniposide—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000116	0.00222	CcSEcCtD
Teniposide—Chest pain—Mitoxantrone—multiple sclerosis	0.000115	0.0022	CcSEcCtD
Teniposide—Diarrhoea—Cladribine—multiple sclerosis	0.000115	0.00219	CcSEcCtD
Teniposide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000115	0.00401	CbGpPWpGaD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000114	0.00401	CbGpPWpGaD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.000114	0.00399	CbGpPWpGaD
Teniposide—Arrhythmia—Prednisolone—multiple sclerosis	0.000114	0.00218	CcSEcCtD
Teniposide—NCOA1—Gene Expression—ZNF746—multiple sclerosis	0.000112	0.00393	CbGpPWpGaD
Teniposide—Feeling abnormal—Azathioprine—multiple sclerosis	0.000112	0.00215	CcSEcCtD
Teniposide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000111	0.00213	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	0.000111	0.0039	CbGpPWpGaD
Teniposide—Confusional state—Mitoxantrone—multiple sclerosis	0.000111	0.00213	CcSEcCtD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000111	0.00388	CbGpPWpGaD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000111	0.00388	CbGpPWpGaD
Teniposide—Oedema—Mitoxantrone—multiple sclerosis	0.00011	0.00211	CcSEcCtD
Teniposide—Infection—Mitoxantrone—multiple sclerosis	0.000109	0.00209	CcSEcCtD
Teniposide—Neutropenia—Prednisone—multiple sclerosis	0.000108	0.00207	CcSEcCtD
Teniposide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000108	0.00206	CcSEcCtD
Teniposide—Abdominal pain—Azathioprine—multiple sclerosis	0.000108	0.00206	CcSEcCtD
Teniposide—Body temperature increased—Azathioprine—multiple sclerosis	0.000108	0.00206	CcSEcCtD
Teniposide—Tachycardia—Mitoxantrone—multiple sclerosis	0.000107	0.00206	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000107	0.00375	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—IL1B—multiple sclerosis	0.000107	0.00374	CbGpPWpGaD
Teniposide—Haemoglobin—Betamethasone—multiple sclerosis	0.000107	0.00204	CcSEcCtD
Teniposide—Haemoglobin—Dexamethasone—multiple sclerosis	0.000107	0.00204	CcSEcCtD
Teniposide—Vomiting—Cladribine—multiple sclerosis	0.000107	0.00204	CcSEcCtD
Teniposide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000106	0.00204	CcSEcCtD
Teniposide—Haemorrhage—Dexamethasone—multiple sclerosis	0.000106	0.00203	CcSEcCtD
Teniposide—Haemorrhage—Betamethasone—multiple sclerosis	0.000106	0.00203	CcSEcCtD
Teniposide—Rash—Cladribine—multiple sclerosis	0.000106	0.00202	CcSEcCtD
Teniposide—Dermatitis—Cladribine—multiple sclerosis	0.000106	0.00202	CcSEcCtD
Teniposide—Anorexia—Mitoxantrone—multiple sclerosis	0.000105	0.00201	CcSEcCtD
Teniposide—Headache—Cladribine—multiple sclerosis	0.000105	0.00201	CcSEcCtD
Teniposide—Arrhythmia—Triamcinolone—multiple sclerosis	0.000104	0.002	CcSEcCtD
Teniposide—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000104	0.002	CcSEcCtD
Teniposide—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000103	0.00197	CcSEcCtD
Teniposide—Hypotension—Mitoxantrone—multiple sclerosis	0.000103	0.00197	CcSEcCtD
Teniposide—NCOA1—Gene Expression—PTBP1—multiple sclerosis	0.000103	0.0036	CbGpPWpGaD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000101	0.00354	CbGpPWpGaD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000101	0.00354	CbGpPWpGaD
Teniposide—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000101	0.00193	CcSEcCtD
Teniposide—Hypersensitivity—Azathioprine—multiple sclerosis	0.0001	0.00192	CcSEcCtD
Teniposide—Nausea—Cladribine—multiple sclerosis	9.95e-05	0.00191	CcSEcCtD
Teniposide—ABCG2—brain—multiple sclerosis	9.93e-05	0.00887	CbGeAlD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	9.89e-05	0.00347	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	9.88e-05	0.0989	CbGdCrCtD
Teniposide—NCOA3—Developmental Biology—PRNP—multiple sclerosis	9.82e-05	0.00344	CbGpPWpGaD
Teniposide—Dyspnoea—Mitoxantrone—multiple sclerosis	9.82e-05	0.00188	CcSEcCtD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	9.81e-05	0.00344	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.79e-05	0.00343	CbGpPWpGaD
Teniposide—NCOA1—IL-6 signaling pathway—IL6—multiple sclerosis	9.75e-05	0.00341	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—SRM—multiple sclerosis	9.65e-05	0.00338	CbGpPWpGaD
Teniposide—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	9.65e-05	0.0966	CbGdCrCtD
Teniposide—Decreased appetite—Mitoxantrone—multiple sclerosis	9.57e-05	0.00183	CcSEcCtD
Teniposide—Hypertension—Prednisolone—multiple sclerosis	9.56e-05	0.00183	CcSEcCtD
Teniposide—Arrhythmia—Dexamethasone—multiple sclerosis	9.48e-05	0.00181	CcSEcCtD
Teniposide—Arrhythmia—Betamethasone—multiple sclerosis	9.48e-05	0.00181	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.46e-05	0.00331	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	9.43e-05	0.0033	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—STAT3—multiple sclerosis	9.43e-05	0.0033	CbGpPWpGaD
Teniposide—Alopecia—Dexamethasone—multiple sclerosis	9.37e-05	0.0018	CcSEcCtD
Teniposide—Alopecia—Betamethasone—multiple sclerosis	9.37e-05	0.0018	CcSEcCtD
Teniposide—Diarrhoea—Azathioprine—multiple sclerosis	9.32e-05	0.00178	CcSEcCtD
Teniposide—Haemoglobin—Prednisone—multiple sclerosis	9.29e-05	0.00178	CcSEcCtD
Teniposide—Haemorrhage—Prednisone—multiple sclerosis	9.24e-05	0.00177	CcSEcCtD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	9.16e-05	0.00321	CbGpPWpGaD
Teniposide—Pancytopenia—Methotrexate—multiple sclerosis	9.16e-05	0.00175	CcSEcCtD
Teniposide—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.07e-05	0.00174	CcSEcCtD
Teniposide—CYP3A4—nervous system—multiple sclerosis	9.05e-05	0.00808	CbGeAlD
Teniposide—Oedema—Prednisolone—multiple sclerosis	9.03e-05	0.00173	CcSEcCtD
Teniposide—Neutropenia—Methotrexate—multiple sclerosis	9.02e-05	0.00173	CcSEcCtD
Teniposide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9e-05	0.00172	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—STAT3—multiple sclerosis	8.94e-05	0.00313	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—MYC—multiple sclerosis	8.93e-05	0.00313	CbGpPWpGaD
Teniposide—Tachycardia—Prednisolone—multiple sclerosis	8.82e-05	0.00169	CcSEcCtD
Teniposide—Hypertension—Triamcinolone—multiple sclerosis	8.79e-05	0.00168	CcSEcCtD
Teniposide—Hypertension—Methylprednisolone—multiple sclerosis	8.77e-05	0.00168	CcSEcCtD
Teniposide—Urticaria—Mitoxantrone—multiple sclerosis	8.75e-05	0.00168	CcSEcCtD
Teniposide—Hyperhidrosis—Prednisolone—multiple sclerosis	8.73e-05	0.00167	CcSEcCtD
Teniposide—CYP3A4—central nervous system—multiple sclerosis	8.72e-05	0.00778	CbGeAlD
Teniposide—Body temperature increased—Mitoxantrone—multiple sclerosis	8.7e-05	0.00167	CcSEcCtD
Teniposide—Abdominal pain—Mitoxantrone—multiple sclerosis	8.7e-05	0.00167	CcSEcCtD
Teniposide—Vomiting—Azathioprine—multiple sclerosis	8.66e-05	0.00166	CcSEcCtD
Teniposide—Rash—Azathioprine—multiple sclerosis	8.59e-05	0.00164	CcSEcCtD
Teniposide—Dermatitis—Azathioprine—multiple sclerosis	8.58e-05	0.00164	CcSEcCtD
Teniposide—Flushing—Prednisone—multiple sclerosis	8.57e-05	0.00164	CcSEcCtD
Teniposide—Headache—Azathioprine—multiple sclerosis	8.53e-05	0.00163	CcSEcCtD
Teniposide—Stomatitis—Methotrexate—multiple sclerosis	8.38e-05	0.00161	CcSEcCtD
Teniposide—Confusional state—Methylprednisolone—multiple sclerosis	8.36e-05	0.0016	CcSEcCtD
Teniposide—Oedema—Triamcinolone—multiple sclerosis	8.31e-05	0.00159	CcSEcCtD
Teniposide—Arrhythmia—Prednisone—multiple sclerosis	8.25e-05	0.00158	CcSEcCtD
Teniposide—Infection—Triamcinolone—multiple sclerosis	8.25e-05	0.00158	CcSEcCtD
Teniposide—Sweating—Methotrexate—multiple sclerosis	8.25e-05	0.00158	CcSEcCtD
Teniposide—Infection—Methylprednisolone—multiple sclerosis	8.23e-05	0.00158	CcSEcCtD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.21e-05	0.00288	CbGpPWpGaD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.21e-05	0.00288	CbGpPWpGaD
Teniposide—Alopecia—Prednisone—multiple sclerosis	8.16e-05	0.00156	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—MAPK1—multiple sclerosis	8.13e-05	0.00285	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—PRNP—multiple sclerosis	8.12e-05	0.00285	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	8.12e-05	0.00284	CbGpPWpGaD
Teniposide—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.11e-05	0.00155	CcSEcCtD
Teniposide—Tachycardia—Triamcinolone—multiple sclerosis	8.11e-05	0.00155	CcSEcCtD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.11e-05	0.00284	CbGpPWpGaD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.11e-05	0.00284	CbGpPWpGaD
Teniposide—Nausea—Azathioprine—multiple sclerosis	8.09e-05	0.00155	CcSEcCtD
Teniposide—Tachycardia—Methylprednisolone—multiple sclerosis	8.09e-05	0.00155	CcSEcCtD
Teniposide—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.03e-05	0.00154	CcSEcCtD
Teniposide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.01e-05	0.00153	CcSEcCtD
Teniposide—NCOA1—Metabolism—SRM—multiple sclerosis	7.98e-05	0.0028	CbGpPWpGaD
Teniposide—Hypertension—Betamethasone—multiple sclerosis	7.97e-05	0.00153	CcSEcCtD
Teniposide—Hypertension—Dexamethasone—multiple sclerosis	7.97e-05	0.00153	CcSEcCtD
Teniposide—Asthenia—Mitoxantrone—multiple sclerosis	7.9e-05	0.00151	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	7.81e-05	0.00274	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—STAT3—multiple sclerosis	7.8e-05	0.00273	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—U2AF2—multiple sclerosis	7.78e-05	0.00273	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—HNRNPA1—multiple sclerosis	7.78e-05	0.00273	CbGpPWpGaD
Teniposide—Haemoglobin—Methotrexate—multiple sclerosis	7.76e-05	0.00149	CcSEcCtD
Teniposide—Hypotension—Methylprednisolone—multiple sclerosis	7.74e-05	0.00148	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.74e-05	0.00271	CbGpPWpGaD
Teniposide—Haemorrhage—Methotrexate—multiple sclerosis	7.72e-05	0.00148	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—PTPRC—multiple sclerosis	7.64e-05	0.00268	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	7.61e-05	0.00267	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	7.61e-05	0.00267	CbGpPWpGaD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	7.58e-05	0.00265	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	7.57e-05	0.00265	CbGpPWpGaD
Teniposide—Oedema—Dexamethasone—multiple sclerosis	7.54e-05	0.00144	CcSEcCtD
Teniposide—Oedema—Betamethasone—multiple sclerosis	7.54e-05	0.00144	CcSEcCtD
Teniposide—Diarrhoea—Mitoxantrone—multiple sclerosis	7.53e-05	0.00144	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.5e-05	0.00263	CbGpPWpGaD
Teniposide—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.5e-05	0.00263	CbGpPWpGaD
Teniposide—Infection—Betamethasone—multiple sclerosis	7.49e-05	0.00143	CcSEcCtD
Teniposide—Infection—Dexamethasone—multiple sclerosis	7.49e-05	0.00143	CcSEcCtD
Teniposide—Feeling abnormal—Prednisolone—multiple sclerosis	7.44e-05	0.00143	CcSEcCtD
Teniposide—Anaemia—Prednisone—multiple sclerosis	7.43e-05	0.00142	CcSEcCtD
Teniposide—Dyspnoea—Triamcinolone—multiple sclerosis	7.41e-05	0.00142	CcSEcCtD
Teniposide—NCOA1—Biological oxidations—POMC—multiple sclerosis	7.4e-05	0.00259	CbGpPWpGaD
Teniposide—Agitation—Prednisone—multiple sclerosis	7.39e-05	0.00142	CcSEcCtD
Teniposide—Thrombocytopenia—Betamethasone—multiple sclerosis	7.38e-05	0.00141	CcSEcCtD
Teniposide—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.38e-05	0.00141	CcSEcCtD
Teniposide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	7.37e-05	0.00258	CbGpPWpGaD
Teniposide—Tachycardia—Betamethasone—multiple sclerosis	7.36e-05	0.00141	CcSEcCtD
Teniposide—Tachycardia—Dexamethasone—multiple sclerosis	7.36e-05	0.00141	CcSEcCtD
Teniposide—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.29e-05	0.0014	CcSEcCtD
Teniposide—Hyperhidrosis—Betamethasone—multiple sclerosis	7.29e-05	0.0014	CcSEcCtD
Teniposide—Anorexia—Betamethasone—multiple sclerosis	7.18e-05	0.00138	CcSEcCtD
Teniposide—Anorexia—Dexamethasone—multiple sclerosis	7.18e-05	0.00138	CcSEcCtD
Teniposide—Urticaria—Prednisolone—multiple sclerosis	7.18e-05	0.00137	CcSEcCtD
Teniposide—Hypotension—Betamethasone—multiple sclerosis	7.04e-05	0.00135	CcSEcCtD
Teniposide—Hypotension—Dexamethasone—multiple sclerosis	7.04e-05	0.00135	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—PGR—multiple sclerosis	7.04e-05	0.00246	CbGpPWpGaD
Teniposide—Vomiting—Mitoxantrone—multiple sclerosis	7e-05	0.00134	CcSEcCtD
Teniposide—Hypertension—Prednisone—multiple sclerosis	6.94e-05	0.00133	CcSEcCtD
Teniposide—Rash—Mitoxantrone—multiple sclerosis	6.94e-05	0.00133	CcSEcCtD
Teniposide—Dermatitis—Mitoxantrone—multiple sclerosis	6.94e-05	0.00133	CcSEcCtD
Teniposide—Chills—Methotrexate—multiple sclerosis	6.93e-05	0.00133	CcSEcCtD
Teniposide—Headache—Mitoxantrone—multiple sclerosis	6.9e-05	0.00132	CcSEcCtD
Teniposide—Feeling abnormal—Triamcinolone—multiple sclerosis	6.85e-05	0.00131	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.84e-05	0.0024	CbGpPWpGaD
Teniposide—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.83e-05	0.00131	CcSEcCtD
Teniposide—Alopecia—Methotrexate—multiple sclerosis	6.82e-05	0.00131	CcSEcCtD
Teniposide—NCOA3—Metabolism—CYP27B1—multiple sclerosis	6.8e-05	0.00238	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CYP24A1—multiple sclerosis	6.8e-05	0.00238	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.78e-05	0.0013	CcSEcCtD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.66e-05	0.00233	CbGpPWpGaD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.66e-05	0.00233	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.66e-05	0.00233	CbGpPWpGaD
Teniposide—Hypersensitivity—Prednisolone—multiple sclerosis	6.65e-05	0.00127	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.65e-05	0.00233	CbGpPWpGaD
Teniposide—Urticaria—Triamcinolone—multiple sclerosis	6.6e-05	0.00126	CcSEcCtD
Teniposide—Urticaria—Methylprednisolone—multiple sclerosis	6.58e-05	0.00126	CcSEcCtD
Teniposide—Body temperature increased—Triamcinolone—multiple sclerosis	6.57e-05	0.00126	CcSEcCtD
Teniposide—Oedema—Prednisone—multiple sclerosis	6.56e-05	0.00126	CcSEcCtD
Teniposide—Abdominal pain—Methylprednisolone—multiple sclerosis	6.55e-05	0.00125	CcSEcCtD
Teniposide—Decreased appetite—Dexamethasone—multiple sclerosis	6.55e-05	0.00125	CcSEcCtD
Teniposide—Decreased appetite—Betamethasone—multiple sclerosis	6.55e-05	0.00125	CcSEcCtD
Teniposide—Nausea—Mitoxantrone—multiple sclerosis	6.54e-05	0.00125	CcSEcCtD
Teniposide—Infection—Prednisone—multiple sclerosis	6.52e-05	0.00125	CcSEcCtD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	6.42e-05	0.00225	CbGpPWpGaD
Teniposide—Tachycardia—Prednisone—multiple sclerosis	6.41e-05	0.00123	CcSEcCtD
Teniposide—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	6.4e-05	0.00224	CbGpPWpGaD
Teniposide—Hyperhidrosis—Prednisone—multiple sclerosis	6.35e-05	0.00122	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—PTPRC—multiple sclerosis	6.32e-05	0.00221	CbGpPWpGaD
Teniposide—Anorexia—Prednisone—multiple sclerosis	6.26e-05	0.0012	CcSEcCtD
Teniposide—NCOA3—Metabolism—GPC5—multiple sclerosis	6.22e-05	0.00218	CbGpPWpGaD
Teniposide—Anaemia—Methotrexate—multiple sclerosis	6.21e-05	0.00119	CcSEcCtD
Teniposide—Feeling abnormal—Betamethasone—multiple sclerosis	6.21e-05	0.00119	CcSEcCtD
Teniposide—Feeling abnormal—Dexamethasone—multiple sclerosis	6.21e-05	0.00119	CcSEcCtD
Teniposide—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.16e-05	0.00118	CcSEcCtD
Teniposide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.16e-05	0.00118	CcSEcCtD
Teniposide—NCOA1—Gene Expression—ZFP36L1—multiple sclerosis	6.15e-05	0.00215	CbGpPWpGaD
Teniposide—Hypersensitivity—Triamcinolone—multiple sclerosis	6.12e-05	0.00117	CcSEcCtD
Teniposide—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.11e-05	0.00117	CcSEcCtD
Teniposide—Leukopenia—Methotrexate—multiple sclerosis	6.02e-05	0.00115	CcSEcCtD
Teniposide—Urticaria—Dexamethasone—multiple sclerosis	5.99e-05	0.00115	CcSEcCtD
Teniposide—Urticaria—Betamethasone—multiple sclerosis	5.99e-05	0.00115	CcSEcCtD
Teniposide—Asthenia—Triamcinolone—multiple sclerosis	5.96e-05	0.00114	CcSEcCtD
Teniposide—Abdominal pain—Dexamethasone—multiple sclerosis	5.96e-05	0.00114	CcSEcCtD
Teniposide—Abdominal pain—Betamethasone—multiple sclerosis	5.96e-05	0.00114	CcSEcCtD
Teniposide—Body temperature increased—Dexamethasone—multiple sclerosis	5.96e-05	0.00114	CcSEcCtD
Teniposide—Body temperature increased—Betamethasone—multiple sclerosis	5.96e-05	0.00114	CcSEcCtD
Teniposide—Asthenia—Methylprednisolone—multiple sclerosis	5.95e-05	0.00114	CcSEcCtD
Teniposide—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	5.88e-05	0.00206	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	5.88e-05	0.00206	CbGpPWpGaD
Teniposide—Pruritus—Triamcinolone—multiple sclerosis	5.88e-05	0.00113	CcSEcCtD
Teniposide—Pruritus—Methylprednisolone—multiple sclerosis	5.86e-05	0.00112	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—STAT3—multiple sclerosis	5.84e-05	0.00205	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	5.82e-05	0.00204	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.8e-05	0.00203	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.8e-05	0.00203	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—STAT3—multiple sclerosis	5.76e-05	0.00202	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	5.74e-05	0.00201	CbGpPWpGaD
Teniposide—Chest pain—Methotrexate—multiple sclerosis	5.72e-05	0.0011	CcSEcCtD
Teniposide—Decreased appetite—Prednisone—multiple sclerosis	5.71e-05	0.00109	CcSEcCtD
Teniposide—Rash—Prednisolone—multiple sclerosis	5.7e-05	0.00109	CcSEcCtD
Teniposide—Dermatitis—Prednisolone—multiple sclerosis	5.69e-05	0.00109	CcSEcCtD
Teniposide—Diarrhoea—Methylprednisolone—multiple sclerosis	5.67e-05	0.00109	CcSEcCtD
Teniposide—Headache—Prednisolone—multiple sclerosis	5.66e-05	0.00108	CcSEcCtD
Teniposide—NCOA1—Metabolism—CYP24A1—multiple sclerosis	5.63e-05	0.00197	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CYP27B1—multiple sclerosis	5.63e-05	0.00197	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	5.61e-05	0.00197	CbGpPWpGaD
Teniposide—Confusional state—Methotrexate—multiple sclerosis	5.53e-05	0.00106	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.5e-05	0.00193	CbGpPWpGaD
Teniposide—Infection—Methotrexate—multiple sclerosis	5.45e-05	0.00104	CcSEcCtD
Teniposide—Feeling abnormal—Prednisone—multiple sclerosis	5.41e-05	0.00104	CcSEcCtD
Teniposide—Asthenia—Dexamethasone—multiple sclerosis	5.41e-05	0.00104	CcSEcCtD
Teniposide—Asthenia—Betamethasone—multiple sclerosis	5.41e-05	0.00104	CcSEcCtD
Teniposide—Thrombocytopenia—Methotrexate—multiple sclerosis	5.37e-05	0.00103	CcSEcCtD
Teniposide—Gastrointestinal pain—Prednisone—multiple sclerosis	5.37e-05	0.00103	CcSEcCtD
Teniposide—Nausea—Prednisolone—multiple sclerosis	5.37e-05	0.00103	CcSEcCtD
Teniposide—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	5.36e-05	0.00188	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	5.36e-05	0.00188	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.35e-05	0.00187	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—TGFB1—multiple sclerosis	5.34e-05	0.00187	CbGpPWpGaD
Teniposide—Pruritus—Dexamethasone—multiple sclerosis	5.33e-05	0.00102	CcSEcCtD
Teniposide—Pruritus—Betamethasone—multiple sclerosis	5.33e-05	0.00102	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	5.31e-05	0.00186	CbGpPWpGaD
Teniposide—Hyperhidrosis—Methotrexate—multiple sclerosis	5.3e-05	0.00102	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.29e-05	0.00185	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.29e-05	0.00185	CbGpPWpGaD
Teniposide—Vomiting—Triamcinolone—multiple sclerosis	5.28e-05	0.00101	CcSEcCtD
Teniposide—Vomiting—Methylprednisolone—multiple sclerosis	5.27e-05	0.00101	CcSEcCtD
Teniposide—Rash—Triamcinolone—multiple sclerosis	5.24e-05	0.001	CcSEcCtD
Teniposide—Dermatitis—Triamcinolone—multiple sclerosis	5.23e-05	0.001	CcSEcCtD
Teniposide—Anorexia—Methotrexate—multiple sclerosis	5.23e-05	0.001	CcSEcCtD
Teniposide—Rash—Methylprednisolone—multiple sclerosis	5.23e-05	0.001	CcSEcCtD
Teniposide—Dermatitis—Methylprednisolone—multiple sclerosis	5.22e-05	0.001	CcSEcCtD
Teniposide—Urticaria—Prednisone—multiple sclerosis	5.21e-05	0.000999	CcSEcCtD
Teniposide—Headache—Triamcinolone—multiple sclerosis	5.2e-05	0.000997	CcSEcCtD
Teniposide—Headache—Methylprednisolone—multiple sclerosis	5.19e-05	0.000994	CcSEcCtD
Teniposide—Abdominal pain—Prednisone—multiple sclerosis	5.19e-05	0.000994	CcSEcCtD
Teniposide—Body temperature increased—Prednisone—multiple sclerosis	5.19e-05	0.000994	CcSEcCtD
Teniposide—Diarrhoea—Dexamethasone—multiple sclerosis	5.16e-05	0.000988	CcSEcCtD
Teniposide—Diarrhoea—Betamethasone—multiple sclerosis	5.16e-05	0.000988	CcSEcCtD
Teniposide—NCOA3—Metabolism—RRM1—multiple sclerosis	5.15e-05	0.00181	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—GPC5—multiple sclerosis	5.14e-05	0.0018	CbGpPWpGaD
Teniposide—Hypotension—Methotrexate—multiple sclerosis	5.13e-05	0.000982	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—TNF—multiple sclerosis	4.98e-05	0.00175	CbGpPWpGaD
Teniposide—Nausea—Triamcinolone—multiple sclerosis	4.93e-05	0.000945	CcSEcCtD
Teniposide—Nausea—Methylprednisolone—multiple sclerosis	4.92e-05	0.000943	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—VDR—multiple sclerosis	4.92e-05	0.00172	CbGpPWpGaD
Teniposide—Dyspnoea—Methotrexate—multiple sclerosis	4.89e-05	0.000937	CcSEcCtD
Teniposide—Hypersensitivity—Prednisone—multiple sclerosis	4.84e-05	0.000926	CcSEcCtD
Teniposide—Vomiting—Betamethasone—multiple sclerosis	4.79e-05	0.000918	CcSEcCtD
Teniposide—Vomiting—Dexamethasone—multiple sclerosis	4.79e-05	0.000918	CcSEcCtD
Teniposide—NCOA1—Gene Expression—PABPC1—multiple sclerosis	4.77e-05	0.00167	CbGpPWpGaD
Teniposide—Decreased appetite—Methotrexate—multiple sclerosis	4.77e-05	0.000913	CcSEcCtD
Teniposide—Rash—Dexamethasone—multiple sclerosis	4.75e-05	0.00091	CcSEcCtD
Teniposide—Rash—Betamethasone—multiple sclerosis	4.75e-05	0.00091	CcSEcCtD
Teniposide—Dermatitis—Dexamethasone—multiple sclerosis	4.75e-05	0.000909	CcSEcCtD
Teniposide—Dermatitis—Betamethasone—multiple sclerosis	4.75e-05	0.000909	CcSEcCtD
Teniposide—Headache—Betamethasone—multiple sclerosis	4.72e-05	0.000904	CcSEcCtD
Teniposide—Headache—Dexamethasone—multiple sclerosis	4.72e-05	0.000904	CcSEcCtD
Teniposide—Asthenia—Prednisone—multiple sclerosis	4.71e-05	0.000902	CcSEcCtD
Teniposide—Pruritus—Prednisone—multiple sclerosis	4.64e-05	0.000889	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.57e-05	0.0016	CbGpPWpGaD
Teniposide—Feeling abnormal—Methotrexate—multiple sclerosis	4.52e-05	0.000866	CcSEcCtD
Teniposide—Diarrhoea—Prednisone—multiple sclerosis	4.49e-05	0.00086	CcSEcCtD
Teniposide—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.49e-05	0.000859	CcSEcCtD
Teniposide—Nausea—Betamethasone—multiple sclerosis	4.48e-05	0.000857	CcSEcCtD
Teniposide—Nausea—Dexamethasone—multiple sclerosis	4.48e-05	0.000857	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—FAS—multiple sclerosis	4.39e-05	0.00154	CbGpPWpGaD
Teniposide—Urticaria—Methotrexate—multiple sclerosis	4.36e-05	0.000835	CcSEcCtD
Teniposide—Abdominal pain—Methotrexate—multiple sclerosis	4.34e-05	0.00083	CcSEcCtD
Teniposide—Body temperature increased—Methotrexate—multiple sclerosis	4.34e-05	0.00083	CcSEcCtD
Teniposide—NCOA1—Gene Expression—RPL5—multiple sclerosis	4.3e-05	0.00151	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—RRM1—multiple sclerosis	4.26e-05	0.00149	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.23e-05	0.00148	CbGpPWpGaD
Teniposide—Vomiting—Prednisone—multiple sclerosis	4.17e-05	0.000799	CcSEcCtD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.17e-05	0.00146	CbGpPWpGaD
Teniposide—Rash—Prednisone—multiple sclerosis	4.14e-05	0.000793	CcSEcCtD
Teniposide—Dermatitis—Prednisone—multiple sclerosis	4.13e-05	0.000792	CcSEcCtD
Teniposide—Headache—Prednisone—multiple sclerosis	4.11e-05	0.000787	CcSEcCtD
Teniposide—Hypersensitivity—Methotrexate—multiple sclerosis	4.04e-05	0.000774	CcSEcCtD
Teniposide—NCOA1—Adipogenesis—IL6—multiple sclerosis	4.02e-05	0.00141	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4e-05	0.0014	CbGpPWpGaD
Teniposide—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.97e-05	0.00139	CbGpPWpGaD
Teniposide—Asthenia—Methotrexate—multiple sclerosis	3.94e-05	0.000754	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	3.91e-05	0.00137	CbGpPWpGaD
Teniposide—Nausea—Prednisone—multiple sclerosis	3.9e-05	0.000747	CcSEcCtD
Teniposide—Pruritus—Methotrexate—multiple sclerosis	3.88e-05	0.000743	CcSEcCtD
Teniposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.77e-05	0.00132	CbGpPWpGaD
Teniposide—Diarrhoea—Methotrexate—multiple sclerosis	3.75e-05	0.000719	CcSEcCtD
Teniposide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	3.54e-05	0.00124	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	3.54e-05	0.00124	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.49e-05	0.00122	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.49e-05	0.00122	CbGpPWpGaD
Teniposide—Vomiting—Methotrexate—multiple sclerosis	3.49e-05	0.000668	CcSEcCtD
Teniposide—Rash—Methotrexate—multiple sclerosis	3.46e-05	0.000662	CcSEcCtD
Teniposide—Dermatitis—Methotrexate—multiple sclerosis	3.46e-05	0.000662	CcSEcCtD
Teniposide—Headache—Methotrexate—multiple sclerosis	3.44e-05	0.000658	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.44e-05	0.0012	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TYK2—multiple sclerosis	3.42e-05	0.0012	CbGpPWpGaD
Teniposide—ABCC6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.41e-05	0.00119	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PGR—multiple sclerosis	3.39e-05	0.00119	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.31e-05	0.00116	CbGpPWpGaD
Teniposide—Nausea—Methotrexate—multiple sclerosis	3.26e-05	0.000624	CcSEcCtD
Teniposide—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.22e-05	0.00113	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.16e-05	0.00111	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.13e-05	0.0011	CbGpPWpGaD
Teniposide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.07e-05	0.00108	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—BCHE—multiple sclerosis	2.96e-05	0.00104	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.84e-05	0.000995	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TYK2—multiple sclerosis	2.83e-05	0.00099	CbGpPWpGaD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.8e-05	0.000981	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	2.75e-05	0.000964	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MMP9—multiple sclerosis	2.69e-05	0.000943	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.59e-05	0.000907	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SRM—multiple sclerosis	2.58e-05	0.000903	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.5e-05	0.000875	CbGpPWpGaD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.49e-05	0.000873	CbGpPWpGaD
Teniposide—NCOA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.46e-05	0.000863	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—BCHE—multiple sclerosis	2.45e-05	0.000858	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—STAT3—multiple sclerosis	2.39e-05	0.000838	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—VDR—multiple sclerosis	2.37e-05	0.000829	CbGpPWpGaD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.27e-05	0.000796	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.26e-05	0.000791	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.26e-05	0.000791	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MMP9—multiple sclerosis	2.23e-05	0.00078	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TGFB1—multiple sclerosis	2.22e-05	0.000777	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.21e-05	0.000774	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MAPK1—multiple sclerosis	2.18e-05	0.000762	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.08e-05	0.00073	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.08e-05	0.000729	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—TNF—multiple sclerosis	2.07e-05	0.000726	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.06e-05	0.000721	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.06e-05	0.000721	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.04e-05	0.000714	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—STAT3—multiple sclerosis	1.98e-05	0.000693	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—MYC—multiple sclerosis	1.95e-05	0.000684	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.94e-05	0.00068	CbGpPWpGaD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.85e-05	0.000647	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SRM—multiple sclerosis	1.85e-05	0.000647	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TGFB1—multiple sclerosis	1.83e-05	0.000643	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.000636	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.000636	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—MAPK1—multiple sclerosis	1.8e-05	0.00063	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—APOE—multiple sclerosis	1.78e-05	0.000624	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—TNF—multiple sclerosis	1.71e-05	0.0006	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—POMC—multiple sclerosis	1.71e-05	0.000599	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—IL6—multiple sclerosis	1.67e-05	0.000585	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.000582	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—POMC—multiple sclerosis	1.53e-05	0.000536	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	1.5e-05	0.000527	CbGpPWpGaD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.5e-05	0.000525	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—APOE—multiple sclerosis	1.47e-05	0.000516	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SRM—multiple sclerosis	1.43e-05	0.0005	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ALB—multiple sclerosis	1.39e-05	0.000489	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—IL6—multiple sclerosis	1.38e-05	0.000484	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.000482	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.32e-05	0.000463	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SRM—multiple sclerosis	1.3e-05	0.000456	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.3e-05	0.000456	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.3e-05	0.000456	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—POMC—multiple sclerosis	1.27e-05	0.000443	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.21e-05	0.000423	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.19e-05	0.000417	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ALB—multiple sclerosis	1.15e-05	0.000404	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.01e-05	0.000354	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.01e-05	0.000352	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.01e-05	0.000352	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	9.87e-06	0.000346	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—RRM1—multiple sclerosis	9.86e-06	0.000345	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.83e-06	0.000344	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—MYC—multiple sclerosis	9.41e-06	0.00033	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—GPC5—multiple sclerosis	9.2e-06	0.000322	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	9.17e-06	0.000321	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	9.17e-06	0.000321	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MYC—multiple sclerosis	9.02e-06	0.000316	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.96e-06	0.000314	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	8.83e-06	0.000309	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SRM—multiple sclerosis	8.59e-06	0.000301	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—GPC5—multiple sclerosis	8.39e-06	0.000294	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.96e-06	0.000279	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.95e-06	0.000279	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—BCHE—multiple sclerosis	7.9e-06	0.000277	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—RRM1—multiple sclerosis	7.62e-06	0.000267	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—RRM1—multiple sclerosis	6.95e-06	0.000243	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	6.05e-06	0.000212	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	6.05e-06	0.000212	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.91e-06	0.000207	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—BCHE—multiple sclerosis	5.66e-06	0.000198	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.53e-06	0.000194	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.39e-06	0.000189	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.08e-06	0.000178	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—APOE—multiple sclerosis	4.76e-06	0.000167	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.63e-06	0.000162	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.63e-06	0.000162	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.58e-06	0.000161	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—BCHE—multiple sclerosis	4.38e-06	0.000153	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.22e-06	0.000148	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—POMC—multiple sclerosis	4.08e-06	0.000143	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—BCHE—multiple sclerosis	3.99e-06	0.00014	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ALB—multiple sclerosis	3.72e-06	0.00013	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—APOE—multiple sclerosis	3.41e-06	0.000119	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—POMC—multiple sclerosis	2.93e-06	0.000103	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ALB—multiple sclerosis	2.67e-06	9.35e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—APOE—multiple sclerosis	2.63e-06	9.23e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.63e-06	9.22e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—APOE—multiple sclerosis	2.4e-06	8.41e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—POMC—multiple sclerosis	2.26e-06	7.93e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—POMC—multiple sclerosis	2.06e-06	7.23e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ALB—multiple sclerosis	2.06e-06	7.23e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ALB—multiple sclerosis	1.88e-06	6.59e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—APOE—multiple sclerosis	1.58e-06	5.55e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—POMC—multiple sclerosis	1.36e-06	4.77e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ALB—multiple sclerosis	1.24e-06	4.35e-05	CbGpPWpGaD
